About this trial
The purpose of this prosective and retrospective observational study is to analyze the clinical and echocardiographic characteristics of infants with prenatal diagnosis of suspected aortic coarctation (CoAo) in order to identify clinical and instrumental elements that can predict the risk of developing aortic coarctation in the neonatal period so that we can identify patients who are at high risk and would therefore require intensive care and observation; compared with low-risk patients, for whom early discharge would be evaluable.
Eligibility criteria
Qualifiers
Patients with pre-natal or post-natal diagnosis of aortic coarctation from 01 January 2000 until approval (retrospective phase) and from approval until 31 December 2026 (prospective phase)
Disqualifiers
Patients whose diagnosis of aortic coarctation is postnatal, considered to be >1 month after birth
prenatal diagnosis of genetic disease (e.g., Turner's Sdr)
coarctation in the setting of complex congenital heart disease
Trial design
Treatments tested in this trial
- Not listed